Vanda Pharmaceuticals Inc. (VNDA)

13.20
0.24 1.80
NASDAQ : Health Technology
Prev Close 13.44
Open 13.44
Day Low/High 13.00 / 13.70
52 Wk Low/High 13.00 / 33.44
Volume 333.45K
Avg Volume 714.90K
Exchange NASDAQ
Shares Outstanding 52.96M
Market Cap 718.72M
EPS 0.50
P/E Ratio 33.10
Div & Yield N.A. (N.A)
Notable Two Hundred Day Moving Average Cross - VNDA

Notable Two Hundred Day Moving Average Cross - VNDA

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $12.90, changing hands as low as $12.70 per share. Vanda Pharmaceuticals Inc shares are currently trading down about 5.7% on the day.

Commit To Purchase Vanda Pharmaceuticals At $10, Earn 23.5% Using Options

Commit To Purchase Vanda Pharmaceuticals At $10, Earn 23.5% Using Options

Investors considering a purchase of Vanda Pharmaceuticals Inc stock, but tentative about paying the going market price of $13.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $10 strike, which has a bid at the time of this writing of $2.35.

Biotech Stock Mailbag: Vanda, Navidea, Provectus

Biotech Stock Mailbag: Vanda, Navidea, Provectus

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "perilous reversal" (up big yesterday but down big today) candidate

Why Vanda Pharmaceuticals (VNDA) Stock Is Surging Today

Why Vanda Pharmaceuticals (VNDA) Stock Is Surging Today

Vanda Pharmaceuticals (VNDA) surged Wednesday after the European Medicines Agency accepted the company's Marketing Authorization Application for Hetlioz, or tasimelteon, a medication that treats non-24-hour sleep-wake disorder.

Bullish Two Hundred Day Moving Average Cross - VNDA

Bullish Two Hundred Day Moving Average Cross - VNDA

In trading on Wednesday, shares of Vanda Pharmaceuticals Inc crossed above their 200 day moving average of $12.15, changing hands as high as $12.43 per share. Vanda Pharmaceuticals Inc shares are currently trading up about 21.3% on the day.

VNDA Makes Notable Cross Below Critical Moving Average

VNDA Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $12.16, changing hands as low as $10.84 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 13.7% on the day.

Oversold Conditions For Vanda Pharmaceuticals (VNDA)

Oversold Conditions For Vanda Pharmaceuticals (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Dead Cat Bounce Stock: Vanda Pharmaceuticals (VNDA)

Today's Dead Cat Bounce Stock: Vanda Pharmaceuticals (VNDA)

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "dead cat bounce" (down big yesterday but up big today) candidate

Investing lessons from the biotech rout

Investing lessons from the biotech rout

This is a month that tested my investment skills.

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Vanda Pharmaceuticals (VNDA) In A Perilous Reversal

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "perilous reversal" (up big yesterday but down big today) candidate

5 Monster Momentum Stocks to Trade

5 Monster Momentum Stocks to Trade

Momentum traders and trend-following traders are basking in profits in this current market.

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "perilous reversal" (up big yesterday but down big today) candidate

Short Interest Drops 15.5% For VNDA

Short Interest Drops 15.5% For VNDA

The most recent short interest data has been released by the NASDAQ for the 01/31/2014 settlement date, which shows a 647,396 share decrease in total short interest for Vanda Pharmaceuticals Inc , to 3,534,318, a decrease of 15.48% since 01/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

22 Biotech Stock Predictions for 2014

22 Biotech Stock Predictions for 2014

TheStreet's Adam Feuerstein offers his biotech stock outlook for 2014 and grades his 2013 predictions.

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's Post-Market Leader Stock

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a post-market leader candidate

Insider Trading Alert - BSX, VNDA, RLGY, SNDK And VRTX Traded By Insiders

Insider Trading Alert - BSX, VNDA, RLGY, SNDK And VRTX Traded By Insiders

Stocks with insider trader activity include BSX, VNDA, RLGY, SNDK and VRTX

Biotech Stock Mailbag: Enanta, Vanda, Pharmacyclics, Top 2014 Stock Catalysts

Biotech Stock Mailbag: Enanta, Vanda, Pharmacyclics, Top 2014 Stock Catalysts

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Vanda Pharma FDA Panel Live Blog

Vanda Pharma FDA Panel Live Blog

An FDA panel will decide whether or not recommend the approval of Vanda's tasimelteon to treat a sleep disorder affecting blind people.

Today's Perilous Reversal Stock: Vanda Pharmaceuticals (VNDA)

Today's Perilous Reversal Stock: Vanda Pharmaceuticals (VNDA)

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "perilous reversal" (up big yesterday but down big today) candidate

Barbarian At The Gate: Vanda Pharmaceuticals (VNDA)

Barbarian At The Gate: Vanda Pharmaceuticals (VNDA)

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Interesting VNDA Put And Call Options For January 2016

Interesting VNDA Put And Call Options For January 2016

Investors in Vanda Pharmaceuticals Inc saw new options become available today, for the January 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 795 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

VNDA January 2015 Options Begin Trading

VNDA January 2015 Options Begin Trading

Investors in Vanda Pharmaceuticals Inc saw new options become available today, for the January 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 435 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta

Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Interesting VNDA Put And Call Options For June 2014

Interesting VNDA Put And Call Options For June 2014

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the June 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Vanda Pharmaceuticals Becomes Oversold (VNDA)

Vanda Pharmaceuticals Becomes Oversold (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks look ready to break out and trade higher from current levels.

4 Biotech Stocks Triggering Breakout Trades

4 Biotech Stocks Triggering Breakout Trades

Keep thees biotech stocks trading on unusual volume on your radar.

TheStreet Quant Rating: C (Hold)